These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

564 related articles for article (PubMed ID: 17558332)

  • 1. Comparison of clinical response to initial highly active antiretroviral therapy in the patients in clinical care in the United States and Brazil.
    Grinsztejn B; Veloso VG; Pilotto JH; Campos DP; Keruly JC; Moore RD
    J Acquir Immune Defic Syndr; 2007 Aug; 45(5):515-20. PubMed ID: 17558332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early mortality and cause of deaths in patients using HAART in Brazil and the United States.
    Grinsztejn B; Veloso VG; Friedman RK; Moreira RI; Luz PM; Campos DP; Pilotto JH; Cardoso SW; Keruly JC; Moore RD
    AIDS; 2009 Oct; 23(16):2107-14. PubMed ID: 19770698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune status at presentation for HIV clinical care in Rio de Janeiro and Baltimore.
    Moreira RI; Luz PM; Struchiner CJ; Morgado M; Veloso VG; Keruly JC; Grinsztejn B; Moore RD
    J Acquir Immune Defic Syndr; 2011 Aug; 57 Suppl 3(Suppl 3):S171-8. PubMed ID: 21857314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalent tuberculosis at HIV diagnosis in Rio de Janeiro, Brazil: the TB/HIV in Rio (THRio) Cohort.
    Saraceni V; Cohn S; Cavalcante SC; Pacheco AG; Moulton LH; Chaisson RE; Durovni B; Golub JE
    J Acquir Immune Defic Syndr; 2014 Sep; 67(1):98-101. PubMed ID: 24933097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival of HIV patients with tuberculosis started on simultaneous or deferred HAART in the THRio cohort, Rio de Janeiro, Brazil.
    Saraceni V; Durovni B; Cavalcante SC; Cohn S; Pacheco AG; Moulton LH; Chaisson RE; Golub JE
    Braz J Infect Dis; 2014; 18(5):491-5. PubMed ID: 24780362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human immunodeficiency virus type 1 (HIV-1) genotyping in Rio de Janeiro, Brazil: assessing subtype and drug-resistance associated mutations in HIV-1 infected individuals failing highly active antiretroviral therapy.
    Couto-Fernandez JC; Silva-de-Jesus C; Veloso VG; Rachid M; Gracie RS; Chequer-Fernandez SL; Oliveira SM; Arakaki-Sanchez D; Chequer PJ; Morgado MG
    Mem Inst Oswaldo Cruz; 2005 Feb; 100(1):73-8. PubMed ID: 15867968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An evaluation of antiretroviral HIV/AIDS treatment in a Rio de Janeiro public clinic.
    Carmody ER; Diaz T; Starling P; dos Santos AP; Sacks HS
    Trop Med Int Health; 2003 May; 8(5):378-85. PubMed ID: 12753630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mortality in HIV-infected women, heterosexual men, and men who have sex with men in Rio de Janeiro, Brazil: an observational cohort study.
    Coelho L; Grinsztejn B; Castilho JL; De Boni R; Quintana MS; Campos DP; Ribeiro SR; Pacheco AG; Veloso VG; Luz PM
    Lancet HIV; 2016 Oct; 3(10):e490-8. PubMed ID: 27658875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of opportunistic illnesses incidence in post combination antiretroviral therapy era in an urban cohort from Rio de Janeiro, Brazil.
    Coelho LE; Cardoso SW; Amancio RT; Moreira RI; Ribeiro SR; Coelho AB; Campos DP; Veloso VG; Grinsztejn B; Luz PM
    BMC Infect Dis; 2016 Mar; 16():134. PubMed ID: 27001753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved virologic outcomes over time for HIV-infected patients on antiretroviral therapy in a cohort from Rio de Janeiro, 1997-2011.
    Martin DA; Luz PM; Lake JE; Clark JL; Veloso VG; Moreira RI; Cardoso SW; Klausner JD; Grinsztejn B
    BMC Infect Dis; 2014 Jun; 14():322. PubMed ID: 24919778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of antiretroviral therapy on the incidence of tuberculosis: the Brazilian experience, 1995-2001.
    Miranda A; Morgan M; Jamal L; Laserson K; Barreira D; Silva G; Santos J; Wells C; Paine P; Garrett D
    PLoS One; 2007 Sep; 2(9):e826. PubMed ID: 17786198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mortality in patients with HIV-1 and tuberculosis co-infection in Rio de Janeiro, Brazil - associated factors and causes of death.
    da Silva Escada RO; Velasque L; Ribeiro SR; Cardoso SW; Marins LMS; Grinsztejn E; da Silva Lourenço MC; Grinsztejn B; Veloso VG
    BMC Infect Dis; 2017 May; 17(1):373. PubMed ID: 28558689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrent tuberculosis in HIV-infected patients in Rio de Janeiro, Brazil.
    Golub JE; Durovni B; King BS; Cavalacante SC; Pacheco AG; Moulton LH; Moore RD; Chaisson RE; Saraceni V
    AIDS; 2008 Nov; 22(18):2527-33. PubMed ID: 19005276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High rates of baseline antiretroviral resistance among HIV-infected pregnant women in an HIV referral centre in Rio de Janeiro, Brazil.
    de Lourdes Teixeira M; Nafea S; Yeganeh N; Santos E; Gouvea MI; Joao E; Ceci L; Bressan C; Cruz ML; Sidi LC; Nielsen-Saines K
    Int J STD AIDS; 2015 Nov; 26(13):922-8. PubMed ID: 25504831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-1 RNA, CD4 T-lymphocytes, and clinical response to highly active antiretroviral therapy.
    Sterling TR; Chaisson RE; Moore RD
    AIDS; 2001 Nov; 15(17):2251-7. PubMed ID: 11698698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Viral load and CD4 count dynamics after HIV-1 seroconversion in homosexual and bisexual men in Rio de Janeiro, Brazil.
    Djomand G; Duerr A; Faulhaber JC; Struchiner CJ; Pacheco AG; Barroso PF; Melo MF; Schechter M
    J Acquir Immune Defic Syndr; 2006 Dec; 43(4):401-4. PubMed ID: 17031316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response to HAART in treatment-naive HIV-infected patients with a prior diagnosis of tuberculosis or other opportunistic infections.
    Dronda F; Sobrino P; Hernández-Novoa B; Caro-Murillo AM; Montero M; Iribarren JA; Sanz J; Del Mar Alonso M; Labarga P; Bernal E; Moreno S;
    Curr HIV Res; 2011 Jun; 9(4):229-36. PubMed ID: 21631429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring the emergence of resistance mutations in patients infected with HIV-1 under salvage therapy with raltegravir in Rio de Janeiro, Brazil: a follow-up study.
    Passaes CP; Guimarães ML; Cardoso SW; Pilotto JH; Veloso V; Grinsztejn B; Morgado MG
    J Med Virol; 2012 Dec; 84(12):1869-75. PubMed ID: 23080489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for AIDS-defining illnesses among a population of poorly adherent people living with HIV/AIDS in Atlanta, Georgia.
    Chow JY; Alsan M; Armstrong W; del Rio C; Marconi VC
    AIDS Care; 2015; 27(7):844-8. PubMed ID: 25660100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virologic and immunologic outcomes and programmatic challenges of an antiretroviral treatment pilot project in Abidjan, Côte d'Ivoire.
    Djomand G; Roels T; Ellerbrock T; Hanson D; Diomande F; Monga B; Maurice C; Nkengasong J; Konan-Koko R; Kadio A; Wiktor S; Lackritz E; Saba J; Chorba T
    AIDS; 2003 Jul; 17 Suppl 3():S5-15. PubMed ID: 14565604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.